Video Summary (AI-Assisted):
Longevity medicine has rapidly evolved from a niche area of interest into one of the fastest-growing fields in healthcare. As clinicians increasingly seek evidence-based interventions that target the biological mechanisms of ageing rather than simply managing disease, mitochondrial health, inflammation and cellular energy production have become central themes.
These topics formed the focus of the recent MedHealth Innovations webinar, hosted by Managing Director Simon Ramshaw. Joining him were two internationally recognised clinicians from different disciplines: functional medicine expert Dr Rob Silverman and aesthetic physician Dr Rita Rakus. Together they explored the emerging role of low-level laser therapy (LLLT), also known as photobiomodulation, in supporting mitochondrial function, reducing inflammation and potentially contributing to healthier ageing.
A changing focus in healthcare
Opening the discussion, Simon Ramshaw explained that MedHealth Innovations represents the same team previously known as Erchonia Lasers, with a renewed emphasis on innovative technologies designed to improve patient outcomes.
He introduced Dr Rob Silverman as a functional medicine practitioner with extensive expertise in nutrition, gut health and metabolic optimisation, while Dr Rita Rakus was recognised as one of the pioneers of aesthetic medicine in the UK, having spent more than three decades adopting and evaluating new technologies.
Despite their different clinical backgrounds, both speakers agreed that longevity medicine is increasingly influencing everyday clinical practice.
From aesthetics to longevity
Dr Rita Rakus reflected on how patient priorities have changed over the past two decades.
Where aesthetic treatments were once primarily focused on helping patients look younger, today’s patients are increasingly interested in maintaining their health, cognitive function and vitality as they age.
She described how this shift led her to explore research from leading longevity institutions, including the Buck Institute for Research on Aging in California and the National University of Singapore.
According to Dr Rakus, many patients now arrive already familiar with concepts such as mitochondrial function, chronic inflammation and vagal nerve activity. Rather than asking solely about cosmetic improvements, they are looking for interventions that support long-term health.
She highlighted several areas that have become increasingly important in clinical practice, including:
- chronic inflammation
- cognitive health and brain fog
- menopausal symptoms
- musculoskeletal recovery
- oral inflammation and gum health
- healthy fat metabolism
Dr Rakus also described how technologies she previously relied upon for fat reduction have gradually been replaced by approaches designed to improve metabolic function rather than destroy fat cells.
Why mitochondria are becoming central to longevity medicine
Dr Silverman’s presentation focused almost entirely on mitochondria, describing them not simply as the “powerhouses of the cell”, but as dynamic signalling centres involved in energy production, inflammation, immune regulation and tissue repair.
He argued that mitochondrial dysfunction may underlie many of the chronic symptoms seen in modern healthcare, including fatigue, reduced resilience and slower recovery.
Rather than viewing genetics as the primary determinant of health, Dr Silverman suggested that lifestyle interventions capable of influencing mitochondrial function may play a much larger role in long-term outcomes.
Looking beyond conventional red light therapy
One of the seminar’s central themes was the distinction between standard red light therapy and the multi-wavelength laser approach discussed throughout the presentation.
Dr Silverman explained that different wavelengths of visible light are believed to interact with different components of the mitochondrial electron transport chain.
He described three principal wavelengths:
- 405 nm violet light, proposed to stimulate Complexes I and II
- 520–532 nm green light, proposed to influence Complex III
- 635 nm red light, proposed to support Complex IV
According to the presentation, using these wavelengths together may support more complete ATP production while reducing the generation of reactive oxygen species.
This concept formed the basis of what the speakers referred to as a “multi-wavelength” approach rather than relying on red light alone.
Inflammation as a common denominator
A recurring theme throughout the webinar was chronic inflammation.
Dr Silverman described inflammation as a major contributor to many age-related conditions and suggested that improving mitochondrial efficiency may help regulate inflammatory pathways.
Particular attention was given to the reported effects of red wavelength laser therapy on inflammatory cytokines, including increased production of the anti-inflammatory cytokine interleukin-10 alongside reductions in several pro-inflammatory mediators.
Although these mechanisms continue to be investigated, the speakers suggested that reducing chronic inflammation may have implications for recovery, pain management and healthy ageing.
The gut–brain–mitochondria connection
One of the most detailed sections of the webinar explored the relationship between gut health and mitochondrial function.
Drawing on functional medicine principles, Dr Silverman described the gut as the body’s largest immune organ and emphasised its close relationship with the nervous system via the vagus nerve.
He proposed that improving gut health may indirectly support brain function through multiple interconnected mechanisms, including:
- improved microbial diversity
- reduced intestinal permeability
- enhanced vagal signalling
- reduced inflammatory burden
- improved mitochondrial communication
Rather than viewing the brain in isolation, he suggested clinicians should consider the gut and mitochondria as part of a connected physiological network.
Why the vagus nerve matters
Another major topic was vagus nerve stimulation.
Dr Silverman described the vagus nerve as one of the body’s most important anti-inflammatory pathways, influencing communication between the brain and the digestive system.
Potential benefits discussed during the seminar included:
- balancing sympathetic and parasympathetic nervous system activity
- reducing chronic inflammation
- improving digestive function
- supporting pain management
- enhancing overall resilience
The speakers described laser stimulation of the vagus nerve as an emerging area of interest within longevity medicine.
Visible light and microbial health
The webinar also explored how different wavelengths of visible light may influence microbial populations.
Dr Silverman reviewed research suggesting that violet wavelengths demonstrate antimicrobial activity against certain bacteria, fungi and viruses under experimental conditions.
He discussed possible applications involving:
- oral health
- skin microbiome support
- gut dysbiosis
- biofilm disruption
Particular emphasis was placed on periodontal disease and its potential relationship with systemic inflammation and neurodegenerative disease, although the speakers acknowledged this remains an active area of research.
Mitochondria as cellular communicators
Perhaps one of the more thought-provoking concepts presented was the idea that mitochondria function not only as energy producers but also as signalling organelles.
Dr Silverman explained emerging research suggesting mitochondria may communicate between tissues, helping coordinate immune responses, inflammation and tissue repair.
If this understanding continues to develop, mitochondrial health may have implications far beyond cellular energy production alone.
The Rainbow Reset protocol
Towards the end of the webinar, Dr Silverman introduced a treatment protocol combining violet, green and red laser wavelengths.
Referred to as the Rainbow Reset, the protocol was described as a 15-minute treatment designed to support:
- mitochondrial function
- vagus nerve activity
- immune balance
- energy production
- cognitive performance
- healthy ageing
The protocol begins with stimulation of the vagus nerve before progressing to other treatment areas, reflecting the speakers’ emphasis on restoring nervous system regulation before addressing wider physiological processes.
Looking ahead
The overarching message from the webinar was that longevity medicine is increasingly shifting towards interventions aimed at improving fundamental cellular processes rather than simply treating symptoms.
Throughout the discussion, Dr Silverman and Dr Rakus repeatedly returned to the same central idea: healthy ageing depends upon maintaining efficient mitochondrial function, regulating inflammation and supporting communication between the body’s interconnected systems.
While many of the mechanisms discussed continue to be investigated and further clinical research is ongoing, the seminar highlighted the growing interest in non-invasive technologies that seek to optimise cellular energy production alongside more traditional medical and lifestyle interventions.
For practitioners interested in longevity medicine, the webinar offered an overview of how photobiomodulation is being integrated into broader discussions around metabolism, inflammation, cognitive health and healthy ageing, illustrating the expanding role of mitochondrial science in modern clinical practice.
